$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
【患者密切关注】为什么更多人选择索非布韦和达卡他韦联合治疗丙肝?
2025-10-19 11:44:20
Check Details
【丙肝患者喜出望外】DAA治疗失败后首选药索磷维伏片来袭
2025-10-19 11:44:20
Check Details
索磷维伏片(吉四代)治疗丙肝的最大优势
2025-10-19 11:44:20
Check Details
索磷维伏片(吉四代)或成丙肝终结者
2025-10-19 11:44:20
Check Details
哪些人适合用索磷维伏片?进口索磷维伏片多少钱一盒?哪个国家产的?
2025-10-19 11:44:20
Check Details
【药物联合】达拉他韦联合索磷布韦治疗丙肝的效果
2025-10-19 11:44:20
Check Details
达拉他韦进入医保了吗?达拉他韦2021年最新价格多少?
2025-10-19 11:44:20
Check Details
索磷布韦是治疗丙肝的最佳药物吗
2025-10-19 11:44:20
Check Details
【联合治疗分析】达拉他韦联合索磷布韦用于丙肝的疗效和安全性
2025-10-19 11:44:20
Check Details
丙肝治愈药索磷布韦片的最新价格
2025-10-19 11:44:20
Check Details
索磷布韦(丙通沙)(吉三代)中文版说明书
2025-10-19 11:44:20
Check Details
告诉你在国内哪里能买到索非布韦药
2025-10-19 11:44:20
Check Details
1
2
...
6061
6062
6063
6064
6065
6066
6067
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sparsentan Drug Interactions: Hypotension, Hyperkalemia, Renal Risk, CYP3A
2
How to Take Vigabatrin: Dosing and Vision Monitoring
3
Who Makes Belzutifan: Welireg and Merck/ MSD Explained
4
FDA Approves Infilbray for GD3 Neurological Symptoms
5
How to Take Selinexor: Dosing, Food, and Safety
6
FDA Approves Nelkarmi for ALK-TKI-Resistant NSCLC
7
FDA Approves Lembaz: First Therapy Shown to Extend Survival in Infantile-Onset NPC
8
Klygefa FDA Approval: Weekly Subcutaneous C5 Inhibition for AChR-Positive gMG
9
What Is Pralsetinib? RET-Positive Lung and Thyroid Cancer Explained
10
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
11
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
12
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring